# BURLINGTON NORTHERN SANTA FE, LLC · Edgar & Edgarette company card

> Burlington Northern Santa Fe saw revenue fall 0.1% in FY2025 to $23.4 billion, operating margin 34.4%, equity 52.7% of assets, and dividend per share up 2 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 934612 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/934612) · [JSON](https://www.pops4.com/boards/company/934612.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $23.4B |
| Revenue growth, 1 year | -0.1% |
| Revenue growth per year | 0.1% |
| Operating margin | 34.4% (prior year 31.9%) |
| Net margin | 23.4% |
| Operating cash flow | $8.1B |
| Capital spending | — |
| Free cash flow | — |
| Cash | $2.5B |
| Long-term debt | $24.0B |
| Total assets | $97.9B |
| Total equity | $51.6B |
| Equity ÷ assets | 52.7% |
| Return on equity | 10.6% |
| Dividend per share | $1.6 |
| Dividend years rising | 2 |

## Readings, computed from those figures

- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Sound ship · one warning sign · slow and jumpy: growing slower than its size class, with revenue that swings more
- Cash Compass: Fading · slow and jumpy, lagging its peers

## Edgarette's reading

Exposure: revenue $23.4B (FY2025), total debt $24.0B. Experience: revenue down 0.1% on the year, up 0.1% a year over 4 years; operating margin 34.4%, up from 31.9%. Soundness: equity 52.7% of assets, return on equity 10.6%, dividend per share up 2 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $20.2B and $24.6B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $18.5B to $26.6B. A statistical range, not company guidance.

Range logged 2026-11-01, receipt e0f03a19d351e8f7, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 10-Q · filed 2026-11-09 · [filing](https://www.sec.gov/Archives/edgar/data/934612/000093461226000017/0000934612-26-000017-index.htm)
- 10-Q · filed 2026-08-10 · [filing](https://www.sec.gov/Archives/edgar/data/934612/000093461226000013/0000934612-26-000013-index.htm)
- 10-Q · filed 2026-05-04 · [filing](https://www.sec.gov/Archives/edgar/data/934612/000093461226000008/0000934612-26-000008-index.htm)
- 10-K · filed 2026-03-02 · [filing](https://www.sec.gov/Archives/edgar/data/934612/000093461226000004/0000934612-26-000004-index.htm)
- 8-K · filed 2025-12-05 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/934612/000119312525308880/0001193125-25-308880-index.htm)
- 10-Q · filed 2025-11-03 · [filing](https://www.sec.gov/Archives/edgar/data/934612/000093461225000028/0000934612-25-000028-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000934612.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=934612

## Cite

POPS4, Edgar & Edgarette: BURLINGTON NORTHERN SANTA FE, LLC company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/934612. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.